Past, Present & Future of Psychedelic-Assisted Therapy: A New Dawn for Mental Health and Neuroscience – cmc.edu

Posted: August 22, 2021 at 3:26 pm

Daniel F. Kelly, M.D. 82 is director of Pacific Neuroscience Institute (PNI) at Providence Saint Johns Health Center and professor of neurosurgery at Saint Johns Cancer Institute in Santa Monica, California. He is internationally recognized for advancing techniques of minimally invasive keyhole and endoscopic brain tumor surgery. He has also overseen development of innovative programs at PNI including the launch of Pacific Brain Health Center in 2018 focused on cognitive, memory and mood disorders, and has been the creative force behind PNIs Treatment & Research in Psychedelics (TRIP) program.

Kelly is a 1982 graduate of Claremont McKenna College where he studied biology and chemistry. He attended Georgetown University School of Medicine and completed a neurosurgical residency training in 1993 at George Washington University Medical Center. He was professor of neurosurgery and vice-chief of clinical affairs for the UCLA Division of Neurosurgery until 2007 when he joined JWCI and Providence Saint Johns Health Center, where he currently serves on the Saint Johns Board of Directors and is chief of neurosurgery.

See the rest here:

Past, Present & Future of Psychedelic-Assisted Therapy: A New Dawn for Mental Health and Neuroscience - cmc.edu

Related Post